Latest News

In a new study, Yale researchers show that moderate calorie restriction in people reduces the production of a protein called SPARC, which then reins in harmful inflammation and improves health in the aged. It could be a target for extending human health span, they report.

While the risks of deaths and hospitalizations from Covid-19 are substantially lower now, navigating this phase of the pandemic can be frustrating and confusing.

A new study released Wednesday shows one way doctors might diagnose who has the chronic condition and indicates a possible way to treat it.

Yale researchers Akiko Iwasaki, PhD, and Harlan Krumholz, MD, are striving to solve the mysteries of long COVID, and to provide a compassionate voice for those feeling isolated and ignored by the medical community.

"We need to educate, maintain, and improve T and B cell responses to prevent severe disease."

CDC analysis of Census data show 29.3% — nearly a third — of adult COVID survivors in Connecticut have experienced lingering symptoms.

Dennis Shung, MD, MHS, PhD, and Benjamin Goldman-Israelow, MD, PhD, are celebrated as the 2022 Iva Dostanic, MD, PhD, Physician-Scientist Trainee Award honorees.

Yale researchers have received a $12 million award from the NIH as part of the Human Immune Project Consortium to study vaccine responses in vulnerable groups, including patients with multiple sclerosis (MS) undergoing B cell depletion therapy, older adults including particularly vulnerable older residents of long-term care facilities, and certain individuals with sickle cell disease.